Grounded Lithium (QB) Stock Quote GRDAF - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.0251

Bid

0.0248

Ask

0.0341

Volume

6,700

0.0251 Day's Range 0.0314

0.0199 52 Week Range 0.1325

Market Cap

1.965M

Previous Close

0.0249

Open

0.0274

Last Trade

2000

0.0251

Last Trade Time

Financial Volume

$ 183

VWAP

0.027285

Average Volume (3m)

43,991

Shares Outstanding

78,279,227

Dividend Yield

PE Ratio

-0.75

Earnings Per Share (EPS)

-0.05

Revenue

1,000

Net Profit

-4.19M

Sector

Miscellaneous Metal Ores,nec

Industry

Miscellaneous Metal Ores,nec

Website

www.groundedlithium.com

Headquarters

Calgary, Alberta, Can

Founded

2015

Grounded Lithium Corporation (QB) is listed in the Miscellaneous Metal Ores sector of the OTCMarkets with ticker GRDAF. The last closing price for Grounded Lithium (QB) was $0.02. Over the last year, Grounded Lithium (QB) shares have traded in a share price range of $ 0.0199 to $ 0.1325.

Grounded Lithium (QB) currently has 78,279,227 shares outstanding. The market capitalization of Grounded Lithium (QB) is $1.95 million. Grounded Lithium (QB) has a price to earnings ratio (PE ratio) of -0.75.

Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in its Oral MAT2203 Compassionate/Expanded Use Access Program

BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S. Perlin

BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024

BEDMINSTER, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

Form 8-K - Current report

Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

Recent $10 million financing expected to fund planned development programs and operations into the second quarter of 2025 Discussions to secure a partner to advance MAT2203 into the Phase 3...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting

BEDMINSTER, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Provide a Business Update on May 9, 2024

BEDMINSTER, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy

BEDMINSTER, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking...

Matinas BioPharma Prices $10 Million Registered Direct Offering

BEDMINSTER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (“Matinas BioPharma” or the “Company”), a clinical-stage biopharmaceutical company...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0033	-11.6197183099	0.0284	0.033	0.0248	4123	0.02605255	CS
4	-0.0009	-3.46153846154	0.026	0.0385	0.0248	23682	0.02880078	CS
12	-0.0121	-32.5268817204	0.0372	0.0388	0.02	43991	0.03132503	CS
26	-0.0361	-58.9869281046	0.0612	0.0617	0.0199	46601	0.03605839	CS
52	-0.0749	-74.9	0.1	0.1325	0.0199	46969	0.05595365	CS
156	-2.4749	-98.996	2.5	2.5	0.0199	67308	0.16189438	CS
260	-2.4749	-98.996	2.5	2.55	0.0199	66289	0.16209172	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BRDSQBird Global Inc (CE)	$ 0.001 (99,900.00%)	23.38k
COGDFCompass Gold Corporation (PK)	$ 0.0491 (12,175.00%)	3k
ASAPQWaitr Holdings Inc (CE)	$ 0.0001 (9,900.00%)	802
AEGYAlternative Energy Partners Inc (CE)	$ 0.0001 (9,900.00%)	1.13M
FONUFONU2 Inc (PK)	$ 0.0001 (9,900.00%)	350k
AMPEAmpio Pharmaceuticals Inc (CE)	$ 0.000001 (-99.91%)	6.81k
WIRXWireless Xcessories Group Inc (CE)	$ 0.000001 (-99.86%)	200
QBIOQ BioMed Inc (CE)	$ 0.000001 (-99.80%)	2.5k
GLBRGlobal Brokerage Inc (CE)	$ 0.000001 (-99.50%)	520
VIAOYVIA optronics AG (CE)	$ 0.0009 (-99.18%)	1.24k
HMBLHUMBL Inc (PK)	$ 0.00026 (4.00%)	135.19M
HIRUHiru Corporation (PK)	$ 0.0038 (46.15%)	126.45M
DPLSDarkPulse Inc (PK)	$ 0.0008 (-11.11%)	95.28M
AITXArtificial Intelligence Technology Solutions Inc (PK)	$ 0.00406 (-4.47%)	89.86M
UBQUUbiquitech Software Corp (PK)	$ 0.000001 (-99.00%)	75.14M